Overview Safety of SPD465 in Treating Adults With ADHD. Status: Completed Trial end date: 2006-11-07 Target enrollment: Participant gender: Summary The purpose of this study is to assess the safety and effectiveness of SPD465 in the treatment of ADHD. The study will also look at how SPD465 affects sleep. Phase: Phase 3 Details Lead Sponsor: ShireTreatments: AdderallAmphetamineDextroamphetamine